PODXL and gastric cancer: In gastric cancer, ADAR2-induced recoded podocalyxin-like (PODXL) (histidine-to-arginine substitution at residue 241) protein was found to suppress tumorigenesis by neutralizing the tumorigenic capacity of wild-type PODXL.